Source:http://linkedlifedata.com/resource/pubmed/id/10027772
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-3-18
|
pubmed:abstractText |
Brain N-acetylaspartate (NAA) can be quantified by in vivo proton magnetic resonance spectroscopy (1H-MRS) and is used in clinical settings as a marker of neuronal density. It is, however, uncertain whether the change in brain NAA content in acute stroke is reliably measured by 1H-MRS and how NAA is distributed within the ischemic area. Rats were exposed to middle cerebral artery occlusion. Preischemic values of [NAA] in striatum were 11 mmol/L by 1H-MRS and 8 mmol/kg by HPLC. The methods showed a comparable reduction during the 8 hours of ischemia. The interstitial level of [NAA] ([NAA]e) was determined by microdialysis using [3H]NAA to assess in vivo recovery. After induction of ischemia, [NAA]e increased linearly from 70 micromol/L to a peak level of 2 mmol/L after 2 to 3 hours before declining to 0.7 mmol/L at 7 hours. For comparison, [NAA]e was measured in striatum during global ischemia, revealing that [NAA]e increased linearly to 4 mmol/L after 3 hours and this level was maintained for the next 4 h. From the change in in vivo recovery of the interstitial space volume marker [14C]mannitol, the relative amount of NAA distributed in the interstitial space was calculated to be 0.2% of the total brain NAA during normal conditions and only 2 to 6% during ischemia. It was concluded that the majority of brain NAA is intracellularly located during ischemia despite large increases of interstitial [NAA]. Thus, MR quantification of NAA during acute ischemia reflects primarily changes in intracellular levels of NAA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0271-678X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
164-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10027772-Acute Disease,
pubmed-meshheading:10027772-Animals,
pubmed-meshheading:10027772-Aspartic Acid,
pubmed-meshheading:10027772-Brain Ischemia,
pubmed-meshheading:10027772-Cerebral Infarction,
pubmed-meshheading:10027772-Corpus Striatum,
pubmed-meshheading:10027772-Magnetic Resonance Spectroscopy,
pubmed-meshheading:10027772-Male,
pubmed-meshheading:10027772-Mannitol,
pubmed-meshheading:10027772-Microdialysis,
pubmed-meshheading:10027772-Osmolar Concentration,
pubmed-meshheading:10027772-Rats,
pubmed-meshheading:10027772-Rats, Sprague-Dawley,
pubmed-meshheading:10027772-Tissue Distribution
|
pubmed:year |
1999
|
pubmed:articleTitle |
N-Acetylaspartate distribution in rat brain striatum during acute brain ischemia.
|
pubmed:affiliation |
Department of Neuroendocrinology, Novo Nordisk A/S, Maaloer, Denmark.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|